motor neurone disease glutathione transferase Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS models Discovery of key mechanism in

185 Besides, other MTHFD2 inhibitors have been reported, including DS18561882 and LY345899 in a substrate-based manner, and treatments based on them decrease cellular NADPH/NADP + ratio, increase cellular ROS levels, and impair tumorigenesis and metastasis

Our meta-analysis is consistent with the results of these previous studies and, as far as we know, this is the first meta-analysis assessing the impact of AOX on TAC and MDA

pmid:15063794 20

So the delivery of GPx3 to breast tumor tissues through hiPSC-MSCs or other methods may promote its expression, and reduce the influence of ROS on the progression of breast cancer accordingly, finally achieve the goal of treating breast cancer